EcoDrugPlus

Ensembl ID : ENSODEG00000007642
Gene Symbol: -
Cross references: -
23 Possible Orthologues:

Ensembl ID : ENSODEG00000018528
Gene Symbol: -
Cross references: -
23 Possible Orthologues:

Ensembl ID : ENSODEG00000019164
Gene Symbol: -
Cross references: -
23 Possible Orthologues:

Ensembl ID : ENSODEG00000020399
Gene Symbol: -
Cross references: -
23 Possible Orthologues:

Ensembl ID : ENSODEG00000019033
Gene Symbol: -
Cross references: -
23 Possible Orthologues:

Ensembl ID : ENSODEG00000019636
Gene Symbol: -
Cross references: -
41 Possible Orthologues:

Ensembl ID : ENSODEG00000001729
Gene Symbol: -
Cross references: -
138 Possible Orthologues:

Ensembl ID : ENSODEG00000001766
Gene Symbol: -
Cross references: -
138 Possible Orthologues:

Ensembl ID : ENSODEG00000012867
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).